Shlomo Brook, MD
- 4Articles
- 8.3KReads1
- 1996–2006Active
- 9Collaborators
About
Shlomo Brook, MD, has published extensively on the treatment of schizophrenia and schizoaffective disorders, with a focus on the use of ziprasidone for managing hostility and acute agitation. His work includes comparative studies of intramuscular ziprasidone versus haloperidol in acute psychosis and investigations into lithium's efficacy in mania. Active in research from 1996 to 2006, Brook has collaborated frequently with authors such as Antony Loebel and Jan Volavka.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
